Patients currently enrolled on the RAMP 203 trial will have the option of continuing treatment with the avutometinib regimen per investigator discretion.

JSKN003 Earns FDA Breakthrough Therapy Designation for HER2-Expressing PROC

0
JSKN003, a biparatopic HER2-targeting antibody drug conjugate (ADC), has been granted breakthrough therapy designation by the FDA as a treatment for adult patients...
Advances in Research & Treatments

Advances in Research & Treatments

0
This year was a good one in the fight against breast cancer. In 2025, a number of meaningful advancements in research brought us closer...
FDA Approval logo

FDA Grants Breakthrough Status to Enhertu for Some HER2+ Early Breast...

0
The U.S. Food and Drug Administration has granted breakthrough therapy designation to Enhertu (fam-trastuzumab deruxtecan-nxki) for adult patients with HER2-positive early breast cancer...
The Top Breast Cancer News of 2025 | Targeted Oncology

The Top Breast Cancer News of 2025 | Targeted Oncology

0
The landscape of breast cancer treatment in 2025 has been defined by significant regulatory approvals and breakthrough clinical data, particularly involving antibody-drug conjugates...
5 breakthrough health innovations in 2025

5 breakthrough health innovations in 2025

0
Get the Popular Science daily newsletter💡 Breakthroughs, discoveries, and DIY tips sent every weekday. For years, needing reading glasses to correct farsightedness...
Could a Psychedelic Breakthrough Expand Trauma Care in Israel?

Could a Psychedelic Breakthrough Expand Trauma Care in Israel?

0
State Comptroller Matanyahu Englman said that in the aftermath of the Oct. 7 Hamas-led...
Abu Dhabi leads world in breakthrough gene replacement therapy 'ITVISMA' for spinal muscular atrophy

Abu Dhabi leads world in breakthrough gene replacement therapy ‘ITVISMA’ for...

0
Abu Dhabi , December 28 (ANI/WAM): Abu Dhabi marks a landmark achievement in becoming the first in the world to deliver ITVISMA (onasemnogene abeparvovec)...
Maurie Markman, MD

JSKN003 Nets FDA Breakthrough Therapy Designation in Pretreated HER2+ Platinum-Resistant Ovarian...

0
JSKN003, a biparatopic HER2-targeted antibody-drug conjugate, has received breakthrough therapy designation from the FDA for the treatment of adult patients with advanced or...
CRISPR Breakthrough Could Rewrite Future of Genetic Disease Treatment

CRISPR Breakthrough Could Rewrite Future of Genetic Disease Treatment

0
A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly developed form of CRISPR...
Aerolase Neo Elite Shows Breakthrough Results In Psoriasis Treatment Case

Aerolase Neo Elite Shows Breakthrough Results In Psoriasis Treatment Case

0
Psoriasis patients struggling with stubborn plaques and chronic...

Recent Posts